Bipolar II or unipolar depression: pharmacologic considerations.
Antai-Otong
Deborah
D
Employee Support Program, VA North Texas Health Care System, Dallas TX, USA. Deborah.Antai-otong@med.va.gov
D000928:Antidepressive Agents / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000451:nursing*; D002986:Clinical Trials as Topic; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000451:nursing*; D006801:Humans; D009730:Nursing Assessment; D009733:Nursing Diagnosis; D016896:Treatment Outcome
D000928:Antidepressive Agents; D018692:Antimanic Agents